2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Mild Dementia: new trials by email Literature Review of Mild Dementia trials Research Report on Mild Dementia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients Roflumilast, Placebo oral tablet - Mild Cognitive Impairment, Mild Dementia | Phase 2 | Unknown | Maastricht University Medical Center | 81 | 2021-11-19 | 2022-04-21 |
| Clinical Trial of a Low Protein Diet in Patients With Cognitive Impairment Fasting-Mimicking Diet ProlonADTM - Mild Cognitive Impairment, Mild Dementia | Phase 1 / Phase 2 | Unknown | University of Genova | 40 | 2019-11-01 | 2022-07-29 |
Cognitive Dysfunction (2) · Alzheimer Disease (1)
Cognition Disorders (2) · Mental Disorders (2) · Neurocognitive Disorders (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Tauopathies (1)
Phosphodiesterase 4 Inhibitors (1) · Roflumilast (1)
Maastricht University Medical Center (1) · University of Genova (1)
Italy (1) · Netherlands (1)
Arjan Blokland, Prof. Dr. (1) · Frans Verhey, Prof. Dr. (1) · Inez Ramakers, Dr. (1) · Jos Prickaerts, Prof. Dr. (1)